MEGLUMINE ANTIMONIATE: 23 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
23
Total FAERS Reports
3 (13.0%)
Deaths Reported
9
Hospitalizations
23
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
First Report: 1994 · Latest Report: 20240101
What Are the Most Common MEGLUMINE ANTIMONIATE Side Effects?
#1 Most Reported
Visceral leishmaniasis
8 reports (34.8%)
#2 Most Reported
Myalgia
8 reports (34.8%)
#3 Most Reported
Electrocardiogram qt prolonged
5 reports (21.7%)
All MEGLUMINE ANTIMONIATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 8 | 34.8% | 0 | 4 |
| Visceral leishmaniasis | 8 | 34.8% | 2 | 5 |
| Arthralgia | 5 | 21.7% | 0 | 1 |
| Decreased appetite | 5 | 21.7% | 1 | 2 |
| Dizziness | 5 | 21.7% | 1 | 2 |
| Electrocardiogram qt prolonged | 5 | 21.7% | 0 | 1 |
Who Reports MEGLUMINE ANTIMONIATE Side Effects? Age & Gender Data
Gender: 33.3% female, 66.7% male. Average age: 52.8 years. Most reports from: GB. View detailed demographics →
Is MEGLUMINE ANTIMONIATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 0 |
| 2024 | 2 | 0 | 0 |
What Is MEGLUMINE ANTIMONIATE Used For?
| Indication | Reports |
|---|---|
| Leishmaniasis | 7 |
| Cutaneous leishmaniasis | 5 |
| Visceral leishmaniasis | 5 |
Official FDA Label for MEGLUMINE ANTIMONIATE
Official prescribing information from the FDA-approved drug label.